A real world cross sectional study assessing the patterns of cladribine tablets treatment among patients with multiple sclerosis of MS LifeLines patient-support program

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2022

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

26 Apr 2022 Results assessing patterns of cladribine tablets treatment among patients with multiple sclerosis (MS) enrolled in the MS LifeLines patient-support program presented at the 74th Annual Meeting of the American Academy of Neurology 2022
07 Apr 2022 New trial record
26 Feb 2022 Results presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2022

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com